vs
Side-by-side financial comparison of PLAYSTUDIOS, Inc. (MYPS) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.
PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $55.4M, roughly 1.5× PLAYSTUDIOS, Inc.). PLAYSTUDIOS, Inc. runs the higher net margin — -24.7% vs -38.1%, a 13.3% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs -18.3%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs -15.6%).
PLAYSTUDIOS, Inc. develops and publishes free-to-play social and casual casino games for mobile, desktop and social platforms. It operates a loyalty rewards program that lets players redeem in-game achievements for real-world benefits including travel, dining and event tickets, serving markets across North America, Europe and Asia Pacific.
PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.
MYPS vs PRCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $55.4M | $83.1M |
| Net Profit | $-13.7M | $-31.6M |
| Gross Margin | — | 64.9% |
| Operating Margin | -17.7% | -4.1% |
| Net Margin | -24.7% | -38.1% |
| Revenue YoY | -18.3% | 20.2% |
| Net Profit YoY | 38.9% | -27.9% |
| EPS (diluted) | $-0.12 | $-0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $83.1M | ||
| Q4 25 | $55.4M | $76.4M | ||
| Q3 25 | $57.6M | $83.3M | ||
| Q2 25 | $59.3M | $79.2M | ||
| Q1 25 | $62.7M | $69.2M | ||
| Q4 24 | $67.8M | $68.2M | ||
| Q3 24 | $71.2M | $58.4M | ||
| Q2 24 | $72.6M | $53.4M |
| Q1 26 | — | $-31.6M | ||
| Q4 25 | $-13.7M | $-29.8M | ||
| Q3 25 | $-9.1M | $-21.4M | ||
| Q2 25 | $-2.9M | $-19.6M | ||
| Q1 25 | $-2.9M | $-24.7M | ||
| Q4 24 | $-22.4M | $-18.9M | ||
| Q3 24 | $-3.1M | $-21.0M | ||
| Q2 24 | $-2.6M | $-25.6M |
| Q1 26 | — | 64.9% | ||
| Q4 25 | — | 60.6% | ||
| Q3 25 | — | 64.8% | ||
| Q2 25 | — | 65.4% | ||
| Q1 25 | — | 63.9% | ||
| Q4 24 | — | 64.0% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 59.0% |
| Q1 26 | — | -4.1% | ||
| Q4 25 | -17.7% | -40.6% | ||
| Q3 25 | -13.6% | -27.8% | ||
| Q2 25 | -5.9% | -28.0% | ||
| Q1 25 | -4.4% | -39.7% | ||
| Q4 24 | -33.1% | -28.9% | ||
| Q3 24 | -6.7% | -38.4% | ||
| Q2 24 | -5.5% | -50.3% |
| Q1 26 | — | -38.1% | ||
| Q4 25 | -24.7% | -39.1% | ||
| Q3 25 | -15.8% | -25.7% | ||
| Q2 25 | -5.0% | -24.7% | ||
| Q1 25 | -4.6% | -35.8% | ||
| Q4 24 | -33.1% | -27.6% | ||
| Q3 24 | -4.3% | -35.9% | ||
| Q2 24 | -3.6% | -48.0% |
| Q1 26 | — | $-0.56 | ||
| Q4 25 | $-0.12 | $-0.54 | ||
| Q3 25 | $-0.07 | $-0.38 | ||
| Q2 25 | $-0.02 | $-0.35 | ||
| Q1 25 | $-0.02 | $-0.45 | ||
| Q4 24 | $-0.18 | $-0.34 | ||
| Q3 24 | $-0.02 | $-0.40 | ||
| Q2 24 | $-0.02 | $-0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $104.9M | $245.6M |
| Total DebtLower is stronger | — | $51.7M |
| Stockholders' EquityBook value | $227.9M | $347.7M |
| Total Assets | $290.6M | $487.1M |
| Debt / EquityLower = less leverage | — | 0.15× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $245.6M | ||
| Q4 25 | $104.9M | $286.5M | ||
| Q3 25 | $106.3M | $294.3M | ||
| Q2 25 | $112.9M | $302.7M | ||
| Q1 25 | $107.1M | $316.2M | ||
| Q4 24 | $109.2M | $333.7M | ||
| Q3 24 | $105.2M | $196.8M | ||
| Q2 24 | $106.3M | $214.1M |
| Q1 26 | — | $51.7M | ||
| Q4 25 | — | $51.6M | ||
| Q3 25 | — | $51.6M | ||
| Q2 25 | — | $51.5M | ||
| Q1 25 | — | $51.5M | ||
| Q4 24 | — | $51.5M | ||
| Q3 24 | — | $51.4M | ||
| Q2 24 | — | $51.4M |
| Q1 26 | — | $347.7M | ||
| Q4 25 | $227.9M | $365.9M | ||
| Q3 25 | $238.9M | $380.3M | ||
| Q2 25 | $245.3M | $385.8M | ||
| Q1 25 | $244.1M | $389.2M | ||
| Q4 24 | $244.7M | $402.2M | ||
| Q3 24 | $265.2M | $241.2M | ||
| Q2 24 | $263.6M | $251.8M |
| Q1 26 | — | $487.1M | ||
| Q4 25 | $290.6M | $508.1M | ||
| Q3 25 | $299.2M | $511.5M | ||
| Q2 25 | $316.2M | $513.1M | ||
| Q1 25 | $313.8M | $519.4M | ||
| Q4 24 | $323.0M | $534.0M | ||
| Q3 24 | $330.6M | $374.1M | ||
| Q2 24 | $333.4M | $374.4M |
| Q1 26 | — | 0.15× | ||
| Q4 25 | — | 0.14× | ||
| Q3 25 | — | 0.14× | ||
| Q2 25 | — | 0.13× | ||
| Q1 25 | — | 0.13× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.21× | ||
| Q2 24 | — | 0.20× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $3.7M | — |
| Free Cash FlowOCF − Capex | $3.6M | — |
| FCF MarginFCF / Revenue | 6.5% | — |
| Capex IntensityCapex / Revenue | 0.2% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $25.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $3.7M | $-10.3M | ||
| Q3 25 | $5.7M | $-6.6M | ||
| Q2 25 | $13.6M | $-15.0M | ||
| Q1 25 | $3.3M | $-17.0M | ||
| Q4 24 | $11.6M | $-32.4M | ||
| Q3 24 | $14.6M | $-18.8M | ||
| Q2 24 | $14.5M | $-15.7M |
| Q1 26 | — | — | ||
| Q4 25 | $3.6M | $-12.2M | ||
| Q3 25 | $5.4M | $-9.5M | ||
| Q2 25 | $13.2M | $-17.8M | ||
| Q1 25 | $3.2M | $-18.8M | ||
| Q4 24 | $11.5M | $-33.6M | ||
| Q3 24 | $13.9M | $-19.0M | ||
| Q2 24 | $12.8M | $-16.8M |
| Q1 26 | — | — | ||
| Q4 25 | 6.5% | -15.9% | ||
| Q3 25 | 9.3% | -11.4% | ||
| Q2 25 | 22.3% | -22.5% | ||
| Q1 25 | 5.1% | -27.2% | ||
| Q4 24 | 16.9% | -49.2% | ||
| Q3 24 | 19.6% | -32.6% | ||
| Q2 24 | 17.6% | -31.4% |
| Q1 26 | — | — | ||
| Q4 25 | 0.2% | 2.4% | ||
| Q3 25 | 0.5% | 3.4% | ||
| Q2 25 | 0.7% | 3.5% | ||
| Q1 25 | 0.2% | 2.7% | ||
| Q4 24 | 0.2% | 1.7% | ||
| Q3 24 | 0.9% | 0.4% | ||
| Q2 24 | 2.4% | 2.0% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MYPS
Segment breakdown not available.
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |
